Acute myelogenous leukemia (AML) remains one of the most formidable hematological malignancies in modern oncology. Despite incremental advances in supportive…
Read More
The oral exposure challenge in PROTACs: What drug developers need to solve early
The landscape of modern pharmacology shifted fundamentally in May 2026, when the U.S. Food and Drug Administration (FDA) granted approval…
Read More
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
The American Association of Pharmaceutical Scientists (AAPS) has announced a strategic shift in the programming for its flagship 2026 PharmSci…
Read More
WuXi XDC and Ona Therapeutics Expand Partnership Through Exclusive Global Licensing Agreement for Advanced Antibody-Drug Conjugate Platform
In a significant expansion of their ongoing strategic partnership, WuXi XDC Cayman has entered into an exclusive global licensing agreement…
Read More
Schrödinger-BMS collaboration centers on Bunsen for trillion-scale computational drug discovery
The landscape of pharmaceutical research is undergoing a structural transformation as Schrödinger, a pioneer in scientific software, announced a strategic…
Read More
Groundbreaking Human Skeletal Blueprint Unveiled: Shedding Light on Congenital Bone Disorders, Osteoarthritis, and Pregnancy Drug Safety
Researchers at the Wellcome Sanger Institute, working alongside an international consortium of collaborators, have published the first comprehensive cellular blueprint…
Read More
The oral exposure challenge in PROTACs: What drug developers need to solve early
Proteolysis Targeting Chimera (PROTAC) technology has transitioned from a theoretical breakthrough to a cornerstone of modern oncology, fundamentally altering how…
Read More
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
The American Association of Pharmaceutical Scientists (AAPS) has unveiled a transformative agenda for its 2026 PharmSci 360 conference, slated for…
Read More
HHS Appoints Four Permanent Senior Leaders to Stabilize and Reform the US Food and Drug Administration Amid Leadership Turmoil
The US Department of Health and Human Services (HHS) has announced the appointment of four permanent senior leaders to critical…
Read More
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Researchers at King’s College London have identified a promising new therapeutic strategy for Alzheimer’s disease by targeting several of the…
Read More
